Post by Curia

In vitro transcription optimization can improve the quality and potency of self-amplifying RNA, a critical step in unlocking the full potential of next generation RNA vaccines and therapeutics. That science is already moving into the clinic. Curia supported Replicate Biosciences and its novel RNA vaccine in clinical trials, demonstrating how process understanding, analytical rigor and scalable manufacturing come together to accelerate development. From early optimization through clinical supply, Curia partners with innovators to help turn promising RNA concepts into real world impact. Download our poster and learn more about Curia’s RNA capabilities at: https://hubs.li/Q04dJp2m0